H. Stoll

发表

A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial.

D. Scheinert, J. Lammer, I. Baumgartner, 2012, Journal of the American College of Cardiology.

2-Year Outcomes of High Bleeding Risk Patients After Polymer-Free Drug-Coated Stents.

S. Pocock, A. Íñiguez, M. Morice, 2017, Journal of the American College of Cardiology.

Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCI.

P. Serruys, J. Tijssen, R. D. de Winter, 2019, Journal of the American College of Cardiology.

Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial.

P. Serruys, R. D. de Winter, J. Wykrzykowska, 2019, European heart journal.

Biolimus A9 polymer-free coated stents in high bleeding risk patients undergoing complex PCI: evidence from the LEADERS FREE randomised clinical trial.

M. Morice, P. Urban, P. Brunel, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Polymer-free Drug-Coated Coronary Stents.

F. Eberli, S. Pocock, A. Íñiguez, 2016, The New England journal of medicine.

Six-Month Results of the NEVO RES-ELUTION I (NEVO RES-I) Trial: A Randomized, Multicenter Comparison of the NEVO Sirolimus-Eluting Coronary Stent With the TAXUS Liberté Paclitaxel-Eluting Stent in De Novo Native Coronary Artery Lesions

P. Fitzgerald, J. Spertus, C. Rogers, 2010, Circulation. Cardiovascular interventions.

Polymer-free biolimus-A9-coated stent for primary percutaneous coronary intervention

F. Jafary, H. Ho, T. Watson, 2019, Herz.

Global Approach to High Bleeding Risk Patients With Polymer-Free Drug-Coated Coronary Stents

Sunil V. Rao, M. Price, S. Pocock, 2020, Circulation. Cardiovascular interventions.

Clinical relevance of ticagrelor monotherapy following 1‐month dual antiplatelet therapy after bifurcation percutaneous coronary intervention: Insight from GLOBAL LEADERS trial

P. Serruys, P. Jüni, S. Garg, 2019, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Drug eluting stent implantation in patients requiring concomitant vitamin K antagonist therapy. One-year outcome of the worldwide e-SELECT registry.

M. Jeong, F. Neumann, S. Ellis, 2013, International journal of cardiology.

Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.

Dick M. Goedhart, P. Serruys, K. Kuck, 2010, Journal of the American College of Cardiology.

Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registry.

M. Jeong, F. Neumann, D. Holmes, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Impact of body mass index on the one-year clinical outcome of patients undergoing multivessel revascularization with sirolimus-eluting stents (from the Arterial Revascularization Therapies Study Part II).

P. Serruys, G. Richardt, J. Daemen, 2008, The American journal of cardiology.

High Resolution ECG and Left Ventricular Volume After Acute Myocardial Infarction

Jens Jung, A. Heisel, H. Stoll, 1994, Pacing and clinical electrophysiology : PACE.

Polymer-free drug-coated vs. bare-metal coronary stents in patients undergoing non-cardiac surgery: a subgroup analysis of the LEADERS FREE trial

M. Morice, P. Urban, F. Krackhardt, 2020, Clinical Research in Cardiology.

Impact of stable versus unstable coronary artery disease on 1-year outcome in elective patients undergoing multivessel revascularization with sirolimus-eluting stents: a subanalysis of the ARTS II trial.

P. Serruys, S. de Servi, M. Valgimigli, 2007, Journal of the American College of Cardiology.

Cineradiography for determination of normal and abnormal function in mechanical heart valves.

H. Schieffer, G. Fröhlig, H. Stoll, 1993, The American journal of cardiology.

Polymer-free drug-coated coronary stents in diabetic patients at high bleeding risk: a pre-specified sub-study of the LEADERS FREE trial

A. Íñiguez, D. Foley, M. Morice, 2018, Clinical Research in Cardiology.

Polymer‐free Biolimus‐A9 coated thin strut stents for patients at high bleeding risk 1‐year results from the LEADERS FREE III study

F. Eberli, S. Cook, M. Morice, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Two-year outcomes of high bleeding risk patients with acute coronary syndrome after Biolimus A9 polymer-free drug-coated stents: a LEADERS FREE substudy.

S. Pocock, M. Morice, P. Urban, 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Long‐term clinical and quality of life outcomes after stenting of femoropopliteal artery stenosis: 3‐year results from the STROLL study

W. Gray, M. Jaff, D. Cohen, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Impact of vascular access on outcome after PCI in patients at high bleeding risk: a pre-specified sub-analysis of the LEADERS FREE trial.

A. Íñiguez, M. Morice, P. Urban, 2020, Revista espanola de cardiologia.

Sirolimus-eluting stents, bare metal stents or coronary artery bypass grafting for patients with multivessel disease including involvement of the proximal left anterior descending artery: analysis of the Arterial Revascularization Therapies study part 2 (ARTS-II)

Dick M. Goedhart, P. Serruys, J. Fajadet, 2009, Heart.

The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularization Therapies Study part II (ARTS II).

Antonio Colombo, Patrick W Serruys, Thierry Lefèvre, 2007, European heart journal.

First-in-man experience with a new 7F vascular closure device (EXOSEAL™): the 7F ECLIPSE study.

S. Fichtlscherer, Florian Hofbauer, C. Hanefeld, 2012, Journal of interventional cardiology.

Drug-Coated Stents Versus Bare-Metal Stents in Academic Research Consortium-Defined High Bleeding Risk Patients.

Sunil V. Rao, S. Pocock, M. Krucoff, 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Sirolimus-Eluting Stents: A Subanalysis of the ARTS II Trial in Elective Patients Undergoing Multivessel Revascularization With Impact of Stable Versus Unstable Coronary Artery Disease on 1-Year Outcome

J. Fajadet, C. Macaya, S. Servi, 2011 .

Selective thrombolysis with rt-PA: a promising approach for the management of embolic cerebrovascular complications during left heart catheterization?

H. Schieffer, C. Ozbek, H. Stoll, 1991, Catheterization and cardiovascular diagnosis.

Experimental validation of a new coronary guide wire labeled with rubidium 81/krypton 81m for continuous assessment of myocardial blood flow

M. Schmitt, M. Menger, B. Vollmar, 2000, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions.

Antonio Colombo, Pascal Vranckx, Patrick W Serruys, 2010, Journal of the American College of Cardiology.

Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model.

M. Böhm, B. Romeike, U. Speck, 2003, European heart journal.

Percutaneous endocardial injection of erythropoietin: Assessment of cardioprotection by electromechanical mapping

K. Kuck, K. Hertting, C. Schneider, 2006, European journal of heart failure.

Sirolimus-eluting versus uncoated stents in acute myocardial infarction.

E. Bramucci, C. Bode, B. Merkely, 2006, The New England journal of medicine.

Pharmacokinetics and consistency of pericardial delivery directed to coronary arteries: Direct comparison with endoluminal delivery

L. Keefer, J. Hrabie, K. March, 1999, Clinical cardiology.

Myocardial metabolic imaging by means of fluorine-18 deoxyglucose/technetium-99m sestamibi dual-isotope single-photon emission tomography

H. Schieffer, C. Alexander, H. Stoll, 1994, European Journal of Nuclear Medicine.

Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention.

P. Serruys, S. de Servi, J. Jukema, 2007, The American journal of cardiology.

Effect of gender differences on early and mid-term clinical outcome after percutaneous or surgical coronary revascularisation in patients with multivessel coronary artery disease: insights from ARTS I and ARTS II.

P. Serruys, C. Stefanadis, M. Morice, 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Myocardial perfusion measured by dual-isotope acquisition of81rubidium/81mkrypton: an experimental verification of the method

H. Schieffer, G. Harbauer, H. Stoll, 1994, Basic Research in Cardiology.

Five-year results of the Multicenter Randomized Controlled Open-Label Study of the CYPHER Sirolimus-Eluting Stent in the Treatment of Diabetic Patients with De Novo Native Coronary Artery Lesions (SCORPIUS) study: a German multicenter investigation on the effectiveness of sirolimus-eluting stents in

W. Voelker, H. Drexler, V. Klauss, 2012, American heart journal.

One-year results of the SCORPIUS study: a German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patients.

H. Drexler, V. Klauss, G. Nickenig, 2007, Journal of the American College of Cardiology.

Safety of Coronary Sirolimus-Eluting Stents in Daily Clinical Practice: One-Year Follow-Up of the e-Cypher Registry

Fesc, P. Guyon, J. E. Sousa, 2006, Circulation.

Sex-Based Outcomes in Patients With a High Bleeding Risk After Percutaneous Coronary Intervention and 1-Month Dual Antiplatelet Therapy: A Secondary Analysis of the LEADERS FREE Randomized Clinical Trial.

R. Mehran, M. Morice, J. Chandrasekhar, 2020, JAMA cardiology.

Sirolimus-eluting versus bare-metal low-profile stent for renal artery treatment (GREAT Trial): angiographic follow-up after 6 months and clinical outcome up to 2 years.

P. Pattynama, W. Jaschke, J. Beregi, 2007, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.

P. Serruys, B. Meier, M. Morice, 2006, JAMA.

Efficacy and Safety of Stents in ST-Segment Elevation Myocardial Infarction.

P. Serruys, G. Stone, L. Räber, 2019, Journal of the American College of Cardiology.

Sirolimus-Eluting versus Bare-Metal Low-Profile Stent for Renal Artery Treatment (GREAT Trial): Angiographic Follow-up after 6 Months and Clinical Outcome up to 2 Years:

P. Pattynama, W. Jaschke, J. Beregi, 2007 .

Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial.

Patrick W Serruys, Eduardo Sousa, Laura Mauri, 2007, Journal of the American College of Cardiology.

S.M.A.R.T. self-expanding nitinol stent for the treatment of atherosclerotic lesions in the superficial femoral artery (STROLL): 1-year outcomes.

W. Gray, M. Jaff, A. Feiring, 2015, Journal of vascular and interventional radiology : JVIR.

Impact of late incomplete stent apposition after sirolimus-eluting stent implantation on 4-year clinical events: intravascular ultrasound analysis from the multicentre, randomised, RAVEL, E-SIRIUS and SIRIUS trials

P. Fitzgerald, P. Serruys, J. Moses, 2007, Heart.

Four-year follow-up of TYPHOON (trial to assess the use of the CYPHer sirolimus-eluting coronary stent in acute myocardial infarction treated with BallOON angioplasty).

E. Bramucci, P. Stella, C. Bode, 2011, JACC. Cardiovascular interventions.

One-year results of coronary revascularization in diabetic patients with multivessel coronary artery disease.Sirolimus stent vs. coronary artery bypass surgery and bare metal stent: insights from ARTS-II and ARTS-I.

P. Serruys, K. Kuck, H. Garcia-Garcia, 2006, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Acute Cardiac Tolerance of Current Contrast Media and the New Taxane Protaxel Using Iopromide as Carrier During Porcine Coronary Angiography and Stenting

M. Böhm, U. Speck, B. Scheller, 2002, Investigative radiology.

Abstract 2150: A European and Canadian Multicenter Randomized, Double-Blind Trial of the Sirolimus-Eluting Stent (SES) in Patients with De Novo Native Coronary Artery Lesions (NEW-SIRIUS): 5-Year Clinical Outcomes

T. Wichter, J. Schofer, M. Schlüter, 2007 .

One-year results of the CRISTAL Trial, a randomized comparison of cypher sirolimus-eluting coronary stents versus balloon angioplasty for restenosis of drug-eluting stents.

J. Fajadet, B. Chevalier, P. Brunel, 2012, Journal of interventional cardiology.

Polymer-free Biolimus A9-coated stents in the treatment of de novo coronary lesions with short DAPT: 9-month angiographic and clinical follow-up of the prospective, multicenter BioFreedom USA clinical trial.

D. Kereiakes, R. Torguson, R. Waksman, 2016, Cardiovascular revascularization medicine : including molecular interventions.

Impact of Ticagrelor Monotherapy on Two-Year Clinical Outcomes in Patients with Long Stenting: A Post Hoc Analysis of the Global Leaders Trial.

P. Serruys, J. Tijssen, R. D. de Winter, 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

P2812Ischemic efficacy and bleeding safety of ticagrelor monotherapy in patients with multivessel percutaneous coronary intervention: insights from the Global Leaders trial

P. Serruys, S. Windecker, M. Valgimigli, 2019, European Heart Journal.

Intracoronary Brachytherapy to Prevent Restenosis Following Coronary Intervention : Is it Ready for Clinical Use ?

H. Stoll, 2022 .

Liquid-Filled Balloon Brachytherapy Using 68Ga Is Effective and Safe Because of the Short 68-Minute Half-Life: Results of a Feasibility Study in the Porcine Coronary Overstretch Model

G. Hutchins, C. Appledorn, K. March, 2001, Circulation.

Advantages of short-lived positron-emitting radioisotopes for intracoronary radiation therapy with liquid-filled balloons to prevent restenosis.

C. Rübe, G. Hutchins, C. Appledorn, 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Three-year follow-up of the ARTS-II# - sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease.

P. Serruys, R. V. van Domburg, M. Morice, 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

First clinical evidence characterizing safety and efficacy of the new CoCr Biolimus-A9 eluting stent: The Biomatrix Alpha™ registry

F. Eberli, C. Macaya, M. Mamas, 2020, International journal of cardiology. Heart & vasculature.

2-Year Outcomes of High Bleeding Risk Patients After Polymer-Free Drug-Coated Stents

M. Morice, I. Menown, T. Hovasse, 2016 .

One-year results of the CRISTAL Trial, a randomized comparison of cypher sirolimus-eluting coronary stents versus balloon angioplasty for restenosis of drug-eluting stents.

J. Fajadet, B. Chevalier, P. Brunel, 2012, Journal of interventional cardiology.

Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk.

M. Morice, P. Garot, R. Zambahari, 2015, The New England journal of medicine.

P. Serruys, S. de Servi, M. Valgimigli, 2007, Journal of the American College of Cardiology.

Short- and long-term health related quality-of-life and anginal status of the Arterial Revascularisation Therapies Study part II, ARTS-II; sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease.

P. Serruys, M. Morice, J. Fajadet, 2010 .